Search for: "State v. Masters" Results 3321 - 3340 of 3,927
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
21 Feb 2019, 4:00 am by Administrator
”[72] Justice L’Heureux-Dubé, however, did not agree that an expression stated in the positive (i.e., a “significant contributing cause”) meant the same thing as one stated in the negative (i.e., “not a trivial cause”). [read post]
16 May 2007, 2:40 pm
  The game, called V-Tech Rampage, offers "three levels of stealth and murder" and is set on a facsimile of the Virginia Tech campus. [read post]
10 Sep 2023, 7:24 pm by Kurt R. Karst
  The final guidance contains a new addition that states that if there is an appropriate justification as to why a sponsor cannot submit patient-level data to FDA through traditional channels, third parties can provide these data through either a pre-IND or Type V Drug Master File (“DMF”) and provide the sponsor with a letter of authorization for FDA to reference the data. [read post]
25 Jul 2014, 6:59 am by Joy Waltemath
While it affirmed summary judgment on her retaliation claim, her sex discrimination claim, in which she alleged that she was treated differently than a male coworker with whom she was having an affair when she was terminated and he was allowed to resign and continue working for an outside contractor, was also revived (Orton-Bell v State of Indiana, July 21, 2014, Manion, D). [read post]
23 Sep 2014, 6:59 am by Joy Waltemath
She asserted that she has a master’s degree in management, is very concerned about limits on her legal rights, and believes arbitration favors employers. [read post]
4 Feb 2011, 7:16 am by INFORRM
Our right to free expression has a natural tension with our right to privacy – see Von Hannover, Campbell v MGN or Mosley v News Group Newspapers. [read post]
18 Jan 2012, 1:55 pm by FDABlog HPM
  FDA previously announced the proposed performance goals and procedures (Fiscal Years 2013 through 2017) for PDUFA V, GDUFA, and BSUFA (here, here, and here), which we reported on here, here, and here. [read post]
2 Aug 2008, 12:54 am
: (Holman’s Biotech IP Blog), Daiichi’s open offer for 20% in Ranbaxy awaits Sebi nod: (GenericsWeb), Australia/India: Strides shows thumbs up for Indian generic industry acquiring controlling interest in Ascent: (Spicy IP), Europe: Significant date ahead for EU Paediatric Regulation: (SPC Blog), India: Grave diggers, ‘immoral’ patent and the National Biotech Regulatory Authority: (Spicy IP), UK: Monster trade mark infringement case: court reveals its thinking… [read post]
7 May 2018, 1:51 pm by Rebecca Tushnet
Relies on member states; referrals go through national authorities. [read post]